Franchise opportunities compared

    Complete Mobile Drug Testing vs Everyday Care

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Complete Mobile Drug Testing discloses more than one business format, so the investment range spans formats; the full report breaks them out.
    • Only neither brand has reviewed Item 19 figures here.
    DisclosureCMComplete Mobile Drug TestingEveryday Care
    Financial commitment
    Estimated initial investment (Item 7)
    $72,350 – $288,150
    2026 FDD · Item 7
    $53,347 – $56,697
    Total Estimated Initial Investment
    2026 FDD · Item 7 · PDF p. 14
    Standard initial franchise fee (Item 5)
    $50,000
    2026 FDD · Item 5 · PDF p. 11
    $49,500
    2026 FDD · Item 5 · PDF p. 11
    Royalty (Item 6)
    $10
    Royalty rate
    2026 FDD · Item 6 · PDF p. 11
    0% of net revenues for each member enrolled into a health plan; payable monthly
    Royalty Fee
    2026 FDD · Item 6 · PDF p. 11
    Brand / advertising fund (Item 6)
    $2.00
    Marketing fund maximum rate
    2026 FDD · Item 6 · PDF p. 11
    Not available
    No reviewed brand or advertising fund fee
    System scale & health
    Total outlets (Item 20)
    1
    Outlets at end of 2024
    2026 FDD · Item 20 · PDF p. 39
    1
    Outlets at end of 2024
    2026 FDD · Item 20 · PDF p. 34
    Net outlet change (Item 20)
    +0
    Calculated: 1 at end of 2022 → 1 at end of 2024
    +1
    Calculated: 0 at end of 2022 → 1 at end of 2024
    Outlet exits (Item 20)
    Not available
    No complete exit records for a year
    Not available
    No complete exit records for a year
    Franchising since (Item 1)
    Not available
    Not in reviewed records
    2024
    2026 FDD · Item 1 · PDF p. 8
    Franchisor founded (Item 1)
    Not available
    Not in reviewed records
    Formed in 2022
    2026 FDD · Item 1 · PDF p. 8
    Performance (Item 19)
    Financial performance (Item 19), by location group
    No reviewed Item 19 figures
    Not disclosed — no Item 19 financial performance representation

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.